Gut microbiome regulation of gut hormone secretion
10.1210/endocr/bqaf004 · doi-reference
Mechanisms of weight loss after obesity surgery
10.1210/endrev/bnab022 · doi-reference
Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor
10.1016/j.soard.2016.02.033 · doi-reference
Upper-gastrointestinal tract metabolite profile regulates glycaemic and satiety responses to meals with contrasting structure: a pilot study
10.1038/s42255-025-01309-7 · doi-reference
Important role of the GLP-1 axis for glucose homeostasis after bariatric surgery
10.1016/j.celrep.2019.01.047 · doi-reference
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
10.1152/ajpgi.00223.2019 · doi-reference
Bile acid metabolism and signaling
10.1002/j.2040-4603.2013.tb00517.x · doi-reference
TGR5-mediated bile acid sensing controls glucose homeostasis
10.1016/j.cmet.2009.08.001 · doi-reference
Orlistat, a new lipase inhibitor for the management of obesity
10.1592/phco.20.4.270.34882 · doi-reference
Combined agonism of nutrient receptors GPR40 and GPR119 with K-757 and K-833 results in weight loss and blood pressure reductions in obese subjects without type 2 diabetes mellitus
10.1111/dom.70120 · doi-reference
Combined GPR40 and GPR119 full agonism with K-757 and K-833 results in robust glucose lowering and modest weight loss in overweight/obese subjects with T2DM
10.1111/dom.70014 · doi-reference
Gut enteroendocrine cell activation using a combination of GPR119 and GPR40 agonists results in synergistic hormone secretion in mice and humans
10.1016/j.cmet.2025.11.001 · doi-reference
Glucagon-like peptide-1: new regulator in lipid metabolism
10.4093/dmj.2023.0277 · doi-reference
Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes
10.1111/dom.14373 · doi-reference
Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes
10.1111/j.1463-1326.2011.01362.x · doi-reference
Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans
10.2337/db13-1654 · doi-reference
Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans
10.1161/atvbaha.112.246207 · doi-reference
Incretin hormones: their role in health and disease
10.1111/dom.13129 · doi-reference
Lipids dysregulation in diseases: core concepts, targets and treatment strategies
10.1186/s12944-024-02425-1 · doi-reference
The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice
10.1053/j.gastro.2012.09.055 · doi-reference
Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells
10.1096/fj.14-259598 · doi-reference
Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
10.1016/j.cell.2015.02.047 · doi-reference
Enterochromaffin 5-HT cells—a major target for GLP-1 and gut microbial metabolites
10.1016/j.molmet.2018.03.004 · doi-reference
Role of the duodenum and macronutrient type in ghrelin regulation
10.1210/en.2004-0609 · doi-reference
Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates
10.1210/jc.2007-2289 · doi-reference
Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women
10.1210/jc.2003-030797 · doi-reference
Nutrient sensing in the gut: new roads to therapeutics?
10.1016/j.tem.2012.11.006 · doi-reference
Bitter taste receptors and α-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying
10.1073/pnas.1011508108 · doi-reference
GOAT links dietary lipids with the endocrine control of energy balance
10.1038/nm.1997 · doi-reference
Sensing of fatty acids for octanoylation of ghrelin involves a gustatory G-protein
10.1371/journal.pone.0040168 · doi-reference
β-Oxidation in ghrelin-producing cells is important for ghrelin acyl-modification
10.1038/s41598-018-27458-2 · doi-reference
High incorporation of long-chain fatty acids contributes to the efficient production of acylated ghrelin in ghrelin-producing cells
10.1002/1873-3468.12132 · doi-reference
Exogenous administration of octanoic acid accelerates octanoylated ghrelin production in the proventriculus of neonatal chicks
10.1016/j.bbrc.2005.05.107 · doi-reference
Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin
10.1210/en.2004-0695 · doi-reference
Acylation, a conductor of ghrelin function in brain health and disease
10.3389/fphys.2022.831641 · doi-reference
Gut–brain circuits for fat preference
10.1038/s41586-022-05266-z · doi-reference
The preference for sugar over sweetener depends on a gut sensor cell
10.1038/s41593-021-00982-7 · doi-reference
A gut-brain neural circuit for nutrient sensory transduction
10.1126/science.aat5236 · doi-reference
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
10.1016/s0140-6736(05)66374-x · doi-reference
Behavioral analysis of marijuana effects on food intake in humans
10.1016/0091-3057(86)90144-9 · doi-reference
